Quratis

Quratis EBIT per Employee

The EBIT per Employee of Quratis (348080.KQ) as of Oct 18, 2026 is -257.92 M KRW. In the previous year, EBIT per Employee was -166.49 M KRW — a change of 54.92% (lower).

EBIT per Employee

-257.92 MKRW

YoY

54.92%

Last updated:

EBIT per Employee of Quratis is 2024 -257.92 M KRW. EBIT per Employee of Quratis was 2023 -166.49 M KRW. It decreases by 54.92% lower compared to the previous year.

The Quratis EBIT per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Employee
Date
EBIT per Employee
Jan 1, 2020
-145.14 M KRW
Jan 1, 2021
-186.62 M KRW
Jan 1, 2023
-166.49 M KRW
Jan 1, 2024
-257.92 M KRW
The Quratis EBIT per Employee history
YEAREBIT per EmployeeYoY
-257.92 MKRW+54.92%
-166.49 MKRW-10.79%
-186.62 MKRW+28.58%
-145.14 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quratis Stock analysis

What does Quratis do? Quratis Inc is a biotechnology company based in Seoul, South Korea, operating within the Health Care sector. The company went public on June 15, 2023, with its stock listed under the ticker 348080.KQ and ISIN KR734808080003. Quratis focuses on research and development in the pharmaceutical industry, specifically developing medicine and pharmaceutical products. The company is involved in the manufacture and sale of vaccines and peptide nucleic acid complexes. It also provides Cell Penetrating Peptide (CPP) platform services. Quratis is engaged in the development and research of vaccines, including tuberculosis vaccines for adults and adolescents and COVID-19 vaccines. The company has 91 employees and maintains a website at http://quratis.com/. Quratis operates in the biotechnology industry, emphasizing innovation in vaccine development and pharmaceutical research. Its headquarters are located in Seoul, South Korea, and it is active in the development of novel therapeutic solutions for global health challenges. The company's activities span from research to commercialization, with a focus on advancing medical treatments through biotechnology. Quratis is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Quratis stock

EBIT per Employee of Quratis is -257.92 M KRW in 2024.

EBIT per Employee of Quratis changed from -166.49 M KRW to -257.92 M KRW, representing a 54.92% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Employee Quratis since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's Quratis historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Quratis

All Key Metrics — Quratis